scholarly article | Q13442814 |
P356 | DOI | 10.1111/TRF.12297 |
P698 | PubMed publication ID | 23781978 |
P50 | author | Paul M Ness | Q107569672 |
P2093 | author name string | Yi Huang | |
Jing Liu | |||
Nan Guo | |||
David J Wright | |||
Hua Shan | |||
Qilu Yu | |||
Jingxing Wang | |||
Mei Huang | |||
Fuzhu Yao | |||
Guoxin Wen | |||
Julin Li | |||
Xiuqiong Wen | |||
Yunlai Lü | |||
Hongli Ma | |||
Mei-hei-li Tiemuer | |||
Weilan He | |||
Xiangming Zhu | |||
Xinhong Bi | |||
Zhongmin Zhou | |||
Zhongqiao Yun | |||
NHLBI Retrovirus Epidemiology Donor Study-II International Component | |||
Ru'an Cao | |||
Tonghan Yang | |||
P2860 | cites work | The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 |
A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt | Q30403548 | ||
Co-infection by hepatitis C virus in HIV-infected patients in southern Brazil: genotype distribution and clinical correlates | Q33576933 | ||
Hepatitis C seroprevalence and associated risk factors, Anyang, China | Q33800604 | ||
Prevalence and trend of hepatitis C virus infection among blood donors in Chinese mainland: a systematic review and meta-analysis | Q33866387 | ||
Who donates blood at five ethnically and geographically diverse blood centers in China in 2008. | Q34121100 | ||
Residual risk of transfusion-transmitted infection with human immunodeficiency virus, hepatitis C virus, and hepatitis B virus in Korea from 2000 through 2010. | Q34346207 | ||
Epidemiology of hepatitis C virus infection among injection drug users in China: systematic review and meta-analysis | Q34779247 | ||
Blood banking in China | Q35024880 | ||
Hepatitis C virus infection, Linxian, China | Q35804327 | ||
The National Heart, Lung, and Blood Institute retrovirus epidemiology donor studies (Retrovirus Epidemiology Donor Study and Retrovirus Epidemiology Donor Study-II): twenty years of research to advance blood product safety and availability | Q36252455 | ||
Injection drug use and HIV/AIDS transmission in China | Q36342046 | ||
Prevalence of serologic markers for hepatitis B and C viruses in Brazilian blood donors and incidence and residual risk of transfusion transmission of hepatitis C virus | Q36403550 | ||
Transmission of hepatitis C virus by blood transfusions and other medical procedures: a global review. | Q36562355 | ||
Systematic review of HIV and HCV infection among drug users in China | Q37487292 | ||
Hepatitis C infection and related factors in hemodialysis patients in china: systematic review and meta-analysis | Q37617380 | ||
The risk of transfusion-transmitted infections in sub-Saharan Africa | Q37618324 | ||
Global burden of hepatitis C: considerations for healthcare providers in the United States | Q42981508 | ||
Residual risk of transfusion-transmitted viral infections in Shenzhen, China, 2001 through 2004. | Q43036225 | ||
Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population | Q43040535 | ||
A multi-Chinese blood center study testing serologic-negative donor samples for hepatitis C virus and human immunodeficiency virus with nucleic acid testing | Q43041674 | ||
A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors | Q44931522 | ||
The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007. | Q44979610 | ||
Rapid transmission of hepatitis C virus among young injecting heroin users in Southern China | Q45654072 | ||
Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services | Q48081521 | ||
International application of the incidence rate/window period model. | Q53307878 | ||
P433 | issue | 10 Pt 2 | |
P921 | main subject | Hepatitis C virus | Q708693 |
viral persistence | Q44134905 | ||
viral transmission | Q123924092 | ||
P304 | page(s) | 2489-2497 | |
P577 | publication date | 2013-06-19 | |
P1433 | published in | Transfusion | Q15758500 |
P1476 | title | The persistence of hepatitis C virus transmission risk in China despite serologic screening of blood donations | |
P478 | volume | 53 |
Q30365797 | Hepatitis C virus infection in China: an emerging public health issue. |
Q37350196 | Molecular epidemiology of hepatitis C infections in Ningxia, China: genotype, phylogeny and mutation analysis |
Q41669992 | Risk factors for hepatitis B and C infection among blood donors in five Chinese blood centers |
Q36157247 | Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses, and Treponema pallidum infections among blood donors at Shiyan, Central China |
Q36187319 | Seroprevalence of transfusion-transmissible infectious agents among volunteer blood donors between 2006 and 2012 in Zhejiang, China |
Q33432155 | Which is safer source plasma for manufacturing in China: apheresis plasma or recovered plasma? |
Search more.